About Geneombio Technologies
Geneombio Technologies is a company based in Pune (India) founded in 2005 by Anagha Sachin Purohit. The company has 29 employees as of April 10, 2024. Geneombio Technologies operates in a competitive market with competitors including BioAgilytix, Alderley Analytical, Tentamus, Nordic Bioscience and Advion, among others.
- Headquarter Pune, India
- Employees 29 as on 10 Apr, 2024
- Founders Anagha Sachin Purohit
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Geneombio Technologies Private Limited
- Date of Incorporation 06 Jul, 2005
- Jurisdiction Haveli, Maharashtra, India
-
Annual Revenue
$900.63 K (USD)72.63as on Mar 31, 2022
-
Net Profit
$2.19 K (USD)100.93as on Mar 31, 2022
-
EBITDA
$125.74 K (USD)192.96as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
-
Employee Count
29
as on Apr 10, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Geneombio Technologies
Investors in Geneombio Technologies
Geneombio Technologies has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Akshay Ingale.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
AI
Akshay Ingale |
-
|
Locked | Locked | Locked |
Investor details for Geneombio Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Geneombio Technologies
Investment portfolio details for Geneombio Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Geneombio Technologies
Detailed financials for Geneombio Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Geneombio Technologies Comparisons
Peer comparison for Geneombio Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Geneombio Technologies
Geneombio Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioAgilytix, Alderley Analytical, Tentamus, Nordic Bioscience and Advion, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Large-molecule bioanalysis is provided for biologics and biosimilars development.
|
|
| Locked | Locked | Locked |
Bioanalytical assays for drug development are developed and validated.
|
|
| Locked | Locked | Locked |
Analytical and quality assurance services are provided for diverse industries.
|
|
| Locked | Locked | Locked |
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
|
|
| Locked | Locked | Locked |
Microfluidics and mass spectrometry products are provided for clinical research.
|
|
| Locked | Locked | Locked |
Integrated R&D services are provided for pharmaceuticals and allied sectors.
|
Detailed competitors of Geneombio Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Geneombio Technologies
Complete news archive for Geneombio Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Geneombio Technologies
Geneombio Technologies was founded in 2005 and raised its 1st funding round 4 years after it was founded.
Geneombio Technologies is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
As of Apr 10, 2024, the latest employee count at Geneombio Technologies is 29.
Annual revenue of Geneombio Technologies is $900.63K as on Mar 31, 2022.
Geneombio Technologies was founded in 2005 in Pune, India, as a genomic services provider. Molecular diagnostic services, such as bacterial and viral pathogen PCR tests, karyotyping, and fluorescent in situ hybridization, are offered. Contract research includes DNA sequencing, cloning, bacterial and fungal identification, DNA fingerprinting, gene expression, and pharmacogenomics. Animal genetic services cover genetic disease testing and karyotyping. Compliance with NABL and DSIR standards is maintained.
Geneombio Technologies's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.
Geneombio Technologies has 1 investor. Key investors include Akshay Ingale.
The valuation of Geneombio Technologies is $5.21M as of Jul 2009.